These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 3093416

  • 21. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
    Hishikawa-Itoh Y, Kato T, Niwa T, Ayakawa Y, Miyata N.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun 20; 24(6):1243-8. PubMed ID: 2794648
    [Abstract] [Full Text] [Related]

  • 22. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ, Horsman MR, Aoki DS.
    Br J Cancer; 1991 Jan 20; 63(1):109-13. PubMed ID: 1846549
    [Abstract] [Full Text] [Related]

  • 23. Perfluorochemical emulsions can increase tumor radiosensitivity.
    Teicher BA, Rose CM.
    Science; 1984 Mar 02; 223(4639):934-6. PubMed ID: 6695191
    [Abstract] [Full Text] [Related]

  • 24. Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor.
    Rockwell S.
    Int J Radiat Oncol Biol Phys; 1985 Jan 02; 11(1):97-103. PubMed ID: 3967986
    [Abstract] [Full Text] [Related]

  • 25. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.
    Cancer J Sci Am; 1995 Jan 02; 1(1):43-8. PubMed ID: 9166453
    [Abstract] [Full Text] [Related]

  • 26. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
    Martin DF, Porter EA, Rockwell S, Fischer JJ.
    Int J Radiat Oncol Biol Phys; 1987 May 02; 13(5):747-51. PubMed ID: 3570898
    [Abstract] [Full Text] [Related]

  • 27. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD, Porter E, Yabuki H, Nath R, Rockwell S.
    Radiat Res; 1990 Nov 02; 124(2):178-82. PubMed ID: 2123353
    [Abstract] [Full Text] [Related]

  • 28. Use of perfluorochemical emulsions in cancer therapy.
    Teicher BA.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Nov 02; 20(2-4):875-82. PubMed ID: 1391527
    [Abstract] [Full Text] [Related]

  • 29. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
    Thomas C, Riess J, Guichard M.
    Int J Radiat Biol; 1991 Feb 02; 59(2):433-45. PubMed ID: 1671693
    [Abstract] [Full Text] [Related]

  • 30. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
    Teicher BA, Herman TS, Hopkins RE, Menon K.
    Int J Radiat Oncol Biol Phys; 1991 Sep 02; 21(4):969-74. PubMed ID: 1917627
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 32. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
    Teicher BA, Holden SA, Rose CM.
    Int J Cancer; 1985 Nov 15; 36(5):585-9. PubMed ID: 3932225
    [Abstract] [Full Text] [Related]

  • 33. Increase in tumor pO2 by perfluorochemicals and carbogen.
    Hasegawa T, Rhee JG, Levitt SH, Song CW.
    Int J Radiat Oncol Biol Phys; 1987 Apr 15; 13(4):569-74. PubMed ID: 3104250
    [Abstract] [Full Text] [Related]

  • 34. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA, Herman TS, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Apr 15; 21(4):286-91. PubMed ID: 3131033
    [Abstract] [Full Text] [Related]

  • 35. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE, Song CW.
    Cancer Chemother Pharmacol; 1989 Apr 15; 25(2):99-102. PubMed ID: 2513138
    [Abstract] [Full Text] [Related]

  • 36. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
    Teicher BA, Holden SA, Cathcart KN, Herman TS.
    J Natl Cancer Inst; 1988 Jun 15; 80(8):599-603. PubMed ID: 2453675
    [Abstract] [Full Text] [Related]

  • 37. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA, Teicher BA, McIntosh NL, Rose CM.
    Anticancer Res; 1987 Jun 15; 7(3 Pt B):385-90. PubMed ID: 3115174
    [Abstract] [Full Text] [Related]

  • 38. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M, Okamoto H, Ohyanaqi H, Saitoh Y, Yano K, Tsuda Y, Ueda Y, Yokoyama K.
    Biomater Artif Cells Artif Organs; 1988 Jun 15; 16(1-3):547-56. PubMed ID: 3140922
    [Abstract] [Full Text] [Related]

  • 39. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA, Holden SA, Rose CM.
    Int J Cancer; 1986 Aug 15; 38(2):285-8. PubMed ID: 3089945
    [Abstract] [Full Text] [Related]

  • 40. Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumours.
    Rockwell S, Kelley M, Irvin CG.
    Int J Radiat Biol; 1992 Jun 15; 61(6):833-9. PubMed ID: 1351534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.